[ad_1]
This marks the company’s 20th patent in the calendar year 2024 and the 10th in the financial year 2024-25, Zen Technologies said in a stock exchange filing..
The T90 Containerised Crew Gunnery Simulator (T90 CGS) is a cutting-edge system designed to enhance the gunnery proficiency of the T-90 tank commander and gunner—key roles critical to an armoured regiment’s combat readiness, Zen Technologies said.
The simulator replicates battlefield conditions and operational scenarios, offering immersive and interactive training experiences with realistic AI-enabled target responses.
The T90 CGS simulates the interior of a T-90 tank turret, featuring two fully equipped stations for the gunner and commander, complete with authentic controls and systems. To ensure a lifelike training experience, the system incorporates a 3-degree-of-freedom motion platform that mimics firing dynamics.
It also offers a high degree of customisation, allowing instructors to tailor training scenarios ranging from individual proficiency exercises to crew coordination under time constraints.
Beyond serving the Indian Armed Forces, the T90 CGS is designed for international markets. It offers foreign militaries a versatile, high-quality training solution that addresses diverse operational needs.
The Hyderabad-based Zen Technologies reported a multi-fold growth in its next profit at ₹62.6 crore in the second quarter of the current fiscal, up from ₹15.3 crore in the same period a year ago. Revenue rose 263% to ₹241.8 crore from ₹66.5 crore during the same period.
As of September 30, 2024, the company’s order book stood at ₹956.74 crore. During the quarter, Zen Technologies also raised ₹100 crore through a Qualified Institutional Placement (QIP).
Last month, the company announced that it secured an annual maintenance contract (AMC) from the Ministry of Defence. The contract, valued at ₹46 crore (inclusive of GST), was disclosed in a stock exchange filing.
Shares of Zen Technologies gained as much as 1.83% to hit an intraday high of ₹1,847 apiece on the BSE on Tuesday. However, the stock pared some of early gains to trade 0.15% higher at ₹1,816.5 apiece on the BSE at 10:46 am.
Also Read: Emcure Pharma shares get an upgrade driven by strong prospects in India, Canada
First Published: Nov 26, 2024 11:32 AM IST
[ad_2]
Source link